CDK Inhibitors approved by PBAC but cost is still an issue 20 April 2018
Giovanna_BCNA
Member Posts: 1,838 ✭
CDK Inhibitors approved by Pharmaceutical Benefits Advisory Committee (PBAC) but cost is still an issue
See the link below for further informationhttps://www.bcna.org.au/news/2018/04/cdk-inhibitors-approved-by-pbac-but-costs-still-an-issue/
Tagged:
1